Cartesian Therapeutics (NASDAQ:RNAC – Get Free Report) posted its quarterly earnings data on Thursday. Cartesian Therapeutics Stock Up 1.0%RNAC stock traded up $0.09 during trading on Friday, reaching $8.85. Get Cartesian Therapeutics alerts:Hedge Funds Weigh In On Cartesian TherapeuticsA number of hedge funds have recently made changes to their positions in RNAC. Public Employees Retirement System of Ohio purchased a new position in Cartesian Therapeutics in the 4th quarter worth approximately $112,000. Read MoreReceive News & Ratings for Cartesian Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cartesian Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.